- Home
- CNXC vs CPRX Comparison
CNXC vs CPRX Comparison
Compare CNXC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXC
- CPRX
- Stock Information
- Founded
- CNXC 1991
- CPRX 2002
- Country
- CNXC United States
- CPRX United States
- Employees
- CNXC N/A
- CPRX N/A
- Industry
- CNXC Computer Software: Prepackaged Software
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CNXC Technology
- CPRX Health Care
- Exchange
- CNXC Nasdaq
- CPRX Nasdaq
- Market Cap
- CNXC 3.6B
- CPRX 2.9B
- IPO Year
- CNXC N/A
- CPRX 2006
- Fundamental
- Price
- CNXC $58.62
- CPRX $21.81
- Analyst Decision
- CNXC Buy
- CPRX Strong Buy
- Analyst Count
- CNXC 4
- CPRX 6
- Target Price
- CNXC $68.75
- CPRX $32.83
- AVG Volume (30 Days)
- CNXC 926.0K
- CPRX 1.4M
- Earning Date
- CNXC 06-26-2025
- CPRX 08-06-2025
- Dividend Yield
- CNXC 2.27%
- CPRX N/A
- EPS Growth
- CNXC N/A
- CPRX 178.13
- EPS
- CNXC 3.65
- CPRX 1.57
- Revenue
- CNXC $9,625,029,000.00
- CPRX $534,645,999.00
- Revenue This Year
- CNXC $2.01
- CPRX $16.37
- Revenue Next Year
- CNXC $2.82
- CPRX $8.80
- P/E Ratio
- CNXC $16.05
- CPRX $13.93
- Revenue Growth
- CNXC 11.31
- CPRX 29.97
- 52 Week Low
- CNXC $36.28
- CPRX $15.34
- 52 Week High
- CNXC $77.00
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- CNXC 57.25
- CPRX 42.36
- Support Level
- CNXC $50.80
- CPRX $20.62
- Resistance Level
- CNXC $61.41
- CPRX $22.06
- Average True Range (ATR)
- CNXC 2.61
- CPRX 0.66
- MACD
- CNXC 0.52
- CPRX 0.03
- Stochastic Oscillator
- CNXC 75.63
- CPRX 56.67
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).